How the US and China can renew the spirit of cooperation to improve world health and the WHO
- Seeing China as a burden on world health rather than a contributor of solutions or dismissing the ‘Health Silk Road’ as a geopolitical ploy are not helpful
- It would be wiser for the US – and China – to view global health more as a public good and less as an extension of development aid
But Covid-19’s continuing ravages present both the US and China with an opportunity not to be wasted. One way to translate rationale into action is to begin by examining the very notion of global health.
01:47
WHO health experts arrive in Covid-19 epicentre Wuhan to investigate origins of coronavirus
The term “global health” started to gain currency in the 1970s, as an extension of concern about global population problems. For decades, global health was part of the West’s broader development aid strategy, to improve health in nations needing economic development.
Implied in such framing is that China, in spite of the help received, has failed to buffer the West against the migration of deadly viruses. Similar sentiments are not difficult to fathom in commentaries about the Covid-19 pandemic. China is thus defined as a burden on global health.
Yet throughout modern history, China has contributed to global health solutions. Identification of the Yersinia pestis bacteria from treatment of the 1894 plague in Hong Kong was a major success in Western medical science. But China’s organisation of an international conference in 1911, in the wake of the northern Manchurian plague, helped to spread medical knowledge, including affirming the utility of face masks.
Between 1850 and 1950, China played a role in the emerging global biomedicines industry, amid its incessant wars, revolutions and famine. The conventional question of whether medical ideas and institutions created in the West were successfully transferred to China is inadequate. International exchange and cooperation are crucial in achieving breakthroughs in epidemic control and the treatment of non-communicable diseases.
After 15 years of collaboration between American and Chinese vaccine developers, the product passed the WHO’s prequalification in 2013, and became available for adoption outside China. Three more Chinese vaccines have acquired the WHO’s prequalification status, with more in the pipeline.
09:50
SCMP Explains: What's the difference between the major Covid-19 vaccines?
The 2015 Nobel Prize in Physiology or Medicine was divided, with one half awarded to Chinese scientists led by Tou Youyou, who found a way to extract artemisinin, used to treat malaria, from a traditional Chinese medicine.
In one sense, China’s public health achievements affirm the value in seeing global health as part of Western development aid. In another sense, China’s help, especially to the Global South, should be viewed as enlarging the pie of health provision.
To promote US-China cooperation, it would be useful to end the politicisation of the WHO. The organisation, like so many other specialised UN agencies, relies on funding from member states, with the US by the far its largest contributor, given that fees are assessed on per capita income.
Voluntary contributions from multinational pharmaceutical corporations enlarge the WHO’s operating budget. Beijing and the country’s health business corporations can and should make a larger monetary contribution to the WHO. Just as importantly, China should work with the WHO and help more countries reap the same public health benefits that it has.
Indeed, it would be wise for both the US and China to view global health less as an extension of development aid, and more as a public good. The assurance of health as a public good requires proportional contributions by all. Such rethinking ought to lead to renewed impetus for global health cooperation between the two, and led by both.
Zha Daojiong is a professor in the School of International Studies, Institute of South-South Cooperation and Development, at Peking University. The article is adapted from a speech presented at a public forum on globalisation on January 23, organised by the Centre for International Security and Strategy at Tsinghua University